Back to search results

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Clear Cell Renal Cell Carcinoma · Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Birmingham, Alabama, United States

  • Research Site, San Diego, California, United States

  • Research Site, Santa Monica, California, United States

  • Research Site, Miami, Florida, United States

  • Research Site, Atlanta, Georgia, United States

  • Research Site, Louisville, Kentucky, United States

  • Research Site, New Orleans, Louisiana, United States

  • Research Site, Baltimore, Maryland, United States

  • Research Site, Boston, Massachusetts, United States

  • Research Site, Detroit, Michigan, United States

  • Research Site, Detroit, Michigan, United States

  • Research Site, Omaha, Nebraska, United States

  • Research Site, New York, New York, United States

  • Research Site, New York, New York, United States

  • Research Site, Cleveland, Ohio, United States

  • Research Site, Cleveland, Ohio, United States

  • Research Site, Pittsburgh, Pennsylvania, United States

  • Research Site, Nashville, Tennessee, United States

  • Research Site, Nashville, Tennessee, United States

  • Research Site, San Antonio, Texas, United States

  • Research Site, Camperdown, Australia

  • Research Site, Melbourne, Australia

  • Research Site, Sydney, Australia

  • Research Site, Seoul, South Korea

  • Research Site, Barcelona, Spain

Study leads

  • Medical Director

    Study Director

    Arcus Biosciences

View source on ClinicalTrials.gov(opens in a new tab)